We are live on ! Find out more
BAMS

Bellevue Asset Management (Switzerland) Portfolio holdings

AUM $656M
1-Year Est. Return 11.45%
This Fund
S&P 500
This Quarter Est. Return
+10.91%
1 Year Est. Return
+11.45%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$656M
AUM Growth
+$43.2M
Cap. Flow
-$10.7M
Cap. Flow %
-1.63%
Top 10 Hldgs %
31%
Holding
140
New
7
Increased
40
Reduced
26
Closed
13

Top Buys

Rank Stock Value
1
CAH icon
Cardinal Health
CAH
+$7.77M
2
CNC icon
Centene
CNC
+$5.07M
3
LCI
Lannett Company, Inc.
LCI
+$4.41M
4
VTRS icon
Viatris
VTRS
+$4.34M
5
CVS icon
CVS Health
CVS
+$4.04M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$13.6M
2
RDY icon
Dr. Reddy's Laboratories
RDY
+$8.31M
3
KITE
Kite Pharma, Inc.
KITE
+$7.43M
4
THC icon
Tenet Healthcare
THC
+$3.82M
5
ABT icon
Abbott
ABT
+$3.6M

Sector Composition

Rank Sector Weight
1 Healthcare 93.1%
2 Financials 1.62%
3 Industrials 0.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AST
126
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
$7K ﹤0.01%
1,875
– –
BTX.WS
127
DELISTED
BioTime Inc Warrants (Expiring October 1, 2018)
BTX.WS
$3K ﹤0.01%
+2,294
New +$2.34K
INVA icon
128
Innoviva
INVA
$1.51B
– –
-35,000
Closed -$251K
LCTX icon
129
Lineage Cell Therapeutics
LCTX
$284M
– –
-2,842
Closed -$2K
LRMR icon
130
Larimar Therapeutics
LRMR
$426M
– –
-8,333
Closed -$3.19M
PEN icon
131
Penumbra
PEN
$12.7B
– –
-10,000
Closed -$401K
RDY icon
132
Dr. Reddy's Laboratories
RDY
$10.1B
– –
-650,000
Closed -$8.31M
XRAY icon
133
Dentsply Sirona
XRAY
$2.76B
– –
-58,400
Closed -$2.95M
LFWD icon
134
ReWalk Robotics
LFWD
$20.4M
– –
-14
Closed -$229K
AKRX
135
DELISTED
Akorn Inc
AKRX
– –
-112,470
Closed -$3.21M
AGN
136
DELISTED
Allergan plc
AGN
– –
-50,150
Closed -$13.6M
UBIO
137
DELISTED
Proshares UltraPro NASDAQ Biotechnology
UBIO
– –
-7,000
Closed -$2.04M
ELGX
138
DELISTED
Endologix Inc
ELGX
– –
-5,000
Closed -$613K
KANG
139
DELISTED
iKang Healthcare Group, Inc.
KANG
– –
-75,000
Closed -$1.11M
DYAX
140
DELISTED
DYAX CORPORATION
DYAX
– –
-15,000
Closed -$286K
2 3 4 5
6

Similar funds

VFAM
Valley Forge Asset Management King Of Prussia, Pennsylvania $645M AUM 5.8% 1-Year Est. Return
MSU
Maple Securities USA Jersey City, New Jersey $672M AUM 1.03% 1-Year Est. Return
PSI
Pinnacle Summer Investments Fairfax, Virginia $678M AUM 9.54% 1-Year Est. Return
SFP
Santa Fe Partners Santa Fe, New Mexico $608M AUM 8.76% 1-Year Est. Return
MCM
Mazama Capital Management Portland, Oregon $544M AUM 9.52% 1-Year Est. Return
NMIS
Northwestern Mutual Investment Services Milwaukee, Wisconsin $525M AUM 2.45% 1-Year Est. Return
SM
Stratton Management King Of Prussia, Pennsylvania $824M AUM 1.55% 1-Year Est. Return
ZAM
Zenit Asset Management Stockholm, Sweden $450M AUM 8.32% 1-Year Est. Return

Bellevue Asset Management (Switzerland)'s Q4 2015 Portfolio in Review

As of Q4 2015, Bellevue Asset Management (Switzerland) held 140 positions worth $656M, up 7% from $613M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Bellevue Asset Management (Switzerland)'s Q4 2015 filing shows 7 new, 40 increased, 26 reduced and 13 closed positions. Its largest new stake was Lannett Company, Inc.: 26,870 shares worth $4.31M. The largest sale was Allergan plc, an estimated $13.6M.

By sector, the portfolio is most concentrated in Healthcare at 93% of assets, up from 92% a quarter earlier, followed by Financials and Industrials.

  • Bellevue Asset Management (Switzerland)'s largest Q4 2015 buy was Lannett Company, Inc.: 26,870 shares worth $4.31M.
  • Bellevue Asset Management (Switzerland) added most to Cardinal Health in Q4 2015, an estimated $7.77M increase.
  • Bellevue Asset Management (Switzerland)'s biggest Q4 2015 reduction was Kite Pharma, Inc., cutting an estimated $7.43M.
  • Bellevue Asset Management (Switzerland) fully exited Allergan plc in Q4 2015, selling an estimated $13.6M.
  • Bellevue Asset Management (Switzerland)'s ten largest holdings make up 31% of its $656M portfolio in Q4 2015.
  • Bellevue Asset Management (Switzerland) opened 7 new positions and closed 13 in Q4 2015.
  • Bellevue Asset Management (Switzerland)'s portfolio value rose 7% quarter-over-quarter to $656M.

Based on Bellevue Asset Management (Switzerland)'s 13F filing for Q4 2015, filed 12 Feb 2016.